Aurobindo gets US FDA nod for risperidone tablets

Aurobindo Pharma, engaged in manufacture of generic pharmaceuticals and active pharmaceutical ingredients with consolidated net sales of Rs 2,435 crore in 2007-08, has received US FDA approval to manufacture and market risperidone tablets 0.25mg, 0.5mg, 1mg, 2 mg, 3mg and 4mg. This is Aurobindo's 81st ANDA approval from the US FDA.